Open Access

When age is not an obstacle: A case series of endoscopic transsphenoidal resection of pituitary macroadenomas in older patients

  • Authors:
    • Konstantinos Faropoulos
    • Ifigeneia Gioti
    • Vasiliki Epameinondas Georgakopoulou
    • Demetrios A. Spandidos
    • Petros Papalexis
    • Ioannis G. Lempesis
    • Nikolaos Trakas
    • Ilias Trakas
    • Andreas Anagiotos
    • George Fotakopoulos
  • View Affiliations

  • Published online on: October 3, 2023     https://doi.org/10.3892/br.2023.1668
  • Article Number: 86
  • Copyright: © Faropoulos et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Due to the increase in life expectancy, the number of elderly patients suffering from a pituitary macroadenoma is expected to increase in the future. The endoscopic endonasal transsphenoidal (EET) approach tends to be the first choice for the treatment of pituitary macroadenomas in the general population. Notwithstanding, in the geriatric population, the goals of management for this condition remain unclear. The present study retrospectively evaluated and describes the cases of 6 patients >70 years of age with a pituitary macroadenoma who were treated by a skull base team, composed of one ENT surgeon and one neurosurgeon. All the patients experienced a notable improvement in their neurological deficit, while their hormonal status also improved or at least did not deteriorate after the surgery. The EET approach appears to be a safe and effective approach for the treatment of pituitary macroadenomas in the geriatric population.

Introduction

Pituitary macroadenomas (PM) are a common subtype of sellar tumors. Considering the gradual extension of human life expectancy, in the near future, neurosurgeons would be expected to face an increasing number of PM cases among the elderly population. Any type of surgical treatment for patients of an advanced age is a debatable issue, as age is accompanied by significant comorbidities, and these patients are prone to developing systemic complications. Thus, a less invasive approach should be used if symptoms occurring due to PM necessitate surgical treatment. The endoscopic endonasal transsphenoidal (EET) approach for the resection of PMs is gradually gaining ground over the standard microscopic transsphenoidal approaches performed over the past decades. The better visualization during the surgery (1-3), the shorter duration of the surgery with fewer intraoperative complications (4-6), the more extensive tumor removal (7,8), and the shorter or equal hospitalization times of patients undergoing the EET approach compared to patients undergoing the microscopic transsphenoidal approach are some of the reasons behind the preference for the use of EET (9-11). It is also important to mention that the long learning curve of the EET approach (200 up to 500 cases) proposed in the past to achieve significantly lower morbidity and mortality (12) and for a number of years constituted an obstacle to the rapid advancement of the latter approach appears to be overestimated. Studies have demonstrated improved or at least comparable results of the EET vs. the microscopic approach after 17 or even fewer surgeries performed using the EET approach (11,13), if the former approach is performed in a multidisciplinary skull base center (11). The present study describes the cases of 6 elderly patients with PM who were treated with the EET approach at Nicosia General Hospital.

Patients and methods

Patients

The present study included patients >70 years who presented with pituitary macroadenomas that were treated surgically using an EET approach. All the patients with a PM that were either <70 years or treated with a different approach than the EET approach were excluded from the study. The patients' data were retrospectively collected and the data obtained included demographics, the extension of tumor removal, intraoperative and late complications, and endocrinology and neurological status pre- and post-operatively. The data were retrieved from the database of the hospital and accessed in an anonymous manner using unique code identifiers, while data were handled in accordance with the protocols of the ethics committee of Nicosia General Hospital (Nicosia, Cyprus). The patient demographics and clinical data, including surgical outcomes, are summarized in Table I.

Table I

Demographics and clinical data of the patients in the present case series.

Table I

Demographics and clinical data of the patients in the present case series.

ParameterPatient 1Patient 2Patient 3Patient 4Patient 5Patient 6
Age, years767173748271
SexFemaleFemaleFemaleMaleMaleFemale
Clinical statusGCS14GCS 15GCS15GCS 14GCS12GCS15
Pituitary hormonal statusNormalNormalAbnormalApoplexyApoplexyNormal
Neurological deficitBilateral visualBilateral visualNoneUnilateral visualUnilateral visualNone
Intraoperative complicationNoneNoneDural tearNoneNoneNone
Late complicationNoneNoneCSF leakNoneNoneNone
OutcomeIMPIMPStable (hormonal replacement)IMPIMP (hormonal replacement)IMP

[i] IMP, improvement; GCS, Glasgow Coma Scale; CSF, cerebrospinal fluid.

The surgeries were performed between 2017 and 2022 by a team consisting of an attending ENT and a neurosurgeon. The nasal stages, including the anterior sphenoidectomy, as well as the final closure, were performed by the ENT surgeon, whereas the remainder of the surgery was performed by the neurosurgeon. For each procedure, a combination of 0˚, 30˚ and 45˚ rigid endoscopes were utilized to achieve adequate exposure and visualization during tumor removal. Abdominal fat was placed in the tumor bed while water-tide closure was ensured using a triple layer of artificial dura, tissue glue and rhino-septal mucosal flaps (Hadad-Bassagasteguy flap). Neuronavigation was routinely utilized in all the cases. The mean duration of hospitalization was 1 week. The hormone levels that are considered ‘normal’ at our institution are the following: Growth hormone, 0-1 µg/l (males) and 0-10 µg/l (females); adrenocorticotropic hormone, 4.7-48.8 ng/l; thyroid-stimulating hormone, 0.35-5.5 mU/l; prolactin, 2.1-17.7 µg/l (males), 2.8-29.2 µg/l (non-pregnant females), 9.7-208 µg/l (pregnant females) and 1.8-20.3 µg/l (menopausal women); follicle-stimulating hormone, 1.4-18.1 mU/l (males), 2.5-10.2 mU/l (females in the follicular phase), 3.4-33.4 mU/l (females in the ovulatory period), 1.5-9.1 mU/l (females in the luteal phase), and 23-116 mU/l (menopausal women); luteinizing hormone, 1.5-9.3 mU/l (males), 1.9-12.5 mU/l (females in the follicular phase), 8.7-76.3 mU/l (females in the ovulatory period), 0.5-16.9 mU/l (females in the luteal phase), and 15.9-54 mU/l (menopausal women).

Results

The clinical data of the 6 patients were as follows:

Patient 1

A 76-year-old female patient was admitted to the Nicosia General Hospital with an acute visual field deficit (significant bitemporal hemianopia). The levels of prolactin were increased, while the levels of other hormones were within normal limits. A macroadenoma with lateral extension to the right cavernous sinus (Knosp grade 3A) was identified in the MRI (Fig. 1), and it was gross-totally removed successfully using the EET approach (Fig. 2). The histological examination of the specimen revealed a prolactinoma. After the surgery, the patient experienced a notable improvement in bitemporal hemianopia (mild visual field restriction was observed in the last follow-up, 6 years after the surgery).

Patient 2

A 71-year-old female patient attended the neurosurgery outpatient clinic at Nicosia General Hospital due to a massive, Knosp grade 2 pituitary macroadenoma that was found incidentally (Fig. 3). In the neurological evaluation, a mild bilateral hemianopia was discovered. The pituitary function was normal. The macroadenoma was endoscopically removed (Fig. 4) with no intra- or post-operative complications, while the histological result was a non-secreting adenoma. The patient's visual fields returned to almost normal levels post-operatively.

Patient 3

A 73-year-old female patient was referred to the neurosurgery outpatient clinic at Nicosia General Hospital by her endocrinologist due to resisting hypothyroidism and hypocortisolemia. The radiological evaluation revealed a Knosp grade 2 pituitary macroadenoma (Fig. 5), which was completely extracted using an EET approach (Fig. 6). The histological examination of the specimen revealed a non-secreting adenoma. The patient developed a post-operative cerebrospinal fluid (CSF) leak, which was successfully treated endoscopically. The patient was discharged with hormonal replacement therapy, even though in the long-term follow-up, her needs for replacement were reduced.

Patient 4

A 74-year-old male patient was urgently transferred to the ER at Nicosia General Hospital due to pituitary apoplexy. He experienced an acute unilateral visual loss, while the pituitary hormone levels were in the lower normal limits. The MRI revealed a Knosp grade 3A pituitary macroadenoma with internal bleeding (Fig. 7). The histological examination of the specimen revealed a non-secreting adenoma. The lesion was extracted successfully (Fig. 8), and the patient's neurological deficit gradually improved (he refers to moderate improvement in his vision shortly after the surgery and a 70% return in vision return 1 year after the surgery).

Patient 5

An 82-year-old male patient was transferred to the ER at Nicosia General Hospital due to an acute change of consciousness and unilateral blindness. The cortisone level was below the normal limit. The MRI revealed a large Knosp grade 2 PM, while signs of blood were also present (Fig. 9). Due to the clinically prominent pituitary apoplexy, the initial treatment plan was to partially remove the tumor, decompressing the optic chiasma; however, as the surgery was uneventful, it was decided to proceed with gross total resection (Fig. 10). The histological examination of the specimen revealed a non-secreting adenoma. The patient's vision gradually improved after the surgery (he refers to a 50% improvement in his vision at 6 months after the surgery); however, he still needs replacement therapy for cortisone.

Patient 6

A 71-year-old female patient presented to the outpatient clinic at Nicosia General Hospital due to headaches. The neurological evaluation did not reveal any notable findings, and the hormonal status was within normal limits. The radiological evaluation revealed a Knosp grade 3A PM with an extension to the right cavernous sinus (Fig. 11), which could not completely explain the patient's symptoms. The tumor was successfully removed (Fig. 12), while the headaches of the patients were reduced in frequency. The histological examination of the specimen revealed a non-secreting adenoma.

Outcomes

All patients experienced a notable improvement in their neurological deficits. Moreover, their endocrinology status either normalized or remained stable. The patients were followed-up in the outpatient clinic after 1 month, 6 months, and then annually post-operatively. An MRI was performed 3 months after the surgery and then annually.

Discussion

The EET approach is gradually gaining ground in the treatment of PMs, compared with the standard microscopic approach. It offers a wider tumor removal, fewer complications and a shorter surgery duration (4,6,7). There is limited literature available on the surgical treatment endpoints for elderly patients with PMs, and which approach has to be utilized in each case. Some previous studies have supported the microscopic transsphenoidal approach for PM resection in patients >65 years (14,15). Their conclusions were supported by a recent study by Azab et al (16), who stated that the microscopic transsphenoidal approach for elderly patients with PM was more efficacious compared with the EET approach. The latter findings are in conflict with those of other studies (17-21), where the EET approach is strongly supported, as it provides a great panoramic view, the ability to perform meticulous and precise intra-operative maneuvers, excellent gross total tumor resection, and improved blood and CSF leak control. Additionally, patients who undergo an EET approach have been shown to achieve shorter hospitalization times (18) compared with patients who undergo a microscopic approach. Notwithstanding, there is a dispute, even in studies focusing on the EET approach. In detail, some researchers have found higher rates of complications in elderly groups (21,22) compared with groups of younger patients with PM who have been treated with an EET approach, while in another study, both young and aged patients had the same complication rates (17). A dispute exists in the duration of hospitalization as well; for example, Fujimoto et al (20) found a longer post-operative hospital duration in the elderly group, while others found the same duration of hospitalization (17,21,22).

In summary, the current trend in the literature is to treat patients of different age groups in a tailored manner. The clear indication for the surgery is either endocrinological, ophthalmological, or neurosurgical, due to the possible space-occupying nature of the tumor, although the endpoint of the treatment may differ. In younger patients with PM, the goal is to perform aggressive tumor removal; hence, in elderly patients, more focus is paid to the improvement of any neurological (the visual deficit is the cardinal target) or hormonal deficit and the avoidance of any possible complications (18). The partial decompression at such advanced ages could translate into a reduced surgery duration and a shorter hospitalization period, with all the complications the latter carries, even if there is a remnant of the tumor (19). The lower rate of recurrence that is observed in elderly patients compared with their younger counterparts supports subtotal tumor removal if it is accompanied by the decompression of the adjacent structures (17), while the choice of a partial decompression of the neural structures with a massive PM remnant is not a viable possibility in younger patients, as the regrowth of the remaining tumor is highly possible.

The management algorithm in the patients described herein did not differ. The original aim was a subtotal extraction of the PM to alleviate the symptoms; notwithstanding, gross total removal was performed as the procedures were uneventful. The outcomes of the patients in the present study are also in parallel with those of the literature, as all the patients with a pre-operation neurological deficit experienced a notable improvement in their deficit (4 out of 4 patients, or 100%), their hormonal status normalized (2 out of 3 patients or 66.6% with pre-operative abnormal hormonal status were discharged with a better hormonal status), and the only complication that was encountered was a post-operative CSF leak (1 out of 6 patients or 16.6%), which was successfully treated endoscopically. Finally, the surgeries were undertaken in a low-volume hospital. Even if the literature suggests that a long learning curve is required to master the EET approach, it is considered that if the surgery is performed by a multidisciplinary skull base team consisting of ENTs and neurosurgeons, the outcome could be excellent for the patient.

Some limitations of present study should be mentioned. The present study was retrospective in nature, which makes it prone to reporting and selection bias. Notwithstanding, all the patients with a PM >70 years of age that were treated with the EET approach in the given period were included. In addition, the group was not uniform, as it was composed of patients with different macroadenoma histologies and clinical presentations. Finally, the small sample size of the series did not allow for a solid statistical analysis. Further studies with a greater number of cases are required the near future in order to allow for a proper analysis and to extract clearer results.

In conclusion, when a physician manages elderly patients with PMs, factors such as life expectancy, comorbidity, neurological deficits and tumor recurrence rate should be taken into consideration. Hence, the goals of treatment are not the same as those in younger patients, where the aim is to perform a complete tumor resection. Considering the low recurrence rate of a remnant in the geriatric population with PMs and the comorbidity that is met at such an age, the partial removal of the tumor with decompression of the neural structures and the normalization of the hormone status is an acceptable choice. The small case series in the present study parallels that of the international literature, supporting EET as an ideal approach for treating PM in patients of an advanced age. That approach can be applied even in centers with a low PM-patient influx, as long as these centers are staffed with a multidisciplinary skull base team. Larger multicenter studies in the future will provide more cases in order to perform a proper statistical analysis which will further support the current findings.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

GF and KF conceptualized the study. KF, GF, AA and IG advised on patient care and medical treatment, and wrote and prepared the draft of the manuscript. GF, KF, IGL, AA, IG, VEG, NT, IT, PP and DAS analyzed the patients' data and provided critical revisions. GF and KF confirm the authenticity of all the data. All authors contributed to manuscript revision and have read and approved the final version of the manuscript.

Ethics approval and consent to participate

The data were retrieved from the database of the hospital and accessed in an anonymous manner using unique code identifiers, while data were handled in accordance with the protocols of the ethics committee of the hospital at Nicosia General Hospital.

Patient consent for publication

Written informed was obtained from the patients for the publication of their data and any accompanying images.

Competing interests

DAS is the Editor-in-Chief for the journal, but had no personal involvement in the reviewing process, or any influence in terms of adjudicating on the final decision, for this article. The other authors declare that they have no competing interests.

References

1 

Jho HD and Carrau RL: Endoscopic endonasal transsphenoidal surgery: Experience with 50 patients. J Neurosurg. 87:44–51. 1997.PubMed/NCBI View Article : Google Scholar

2 

Jho HD, Carrau RL, Ko Y and Daly MA: Endoscopic pituitary surgery: An early experience. Surg Neurol. 47:213–222; discussion 222-3. 1997.PubMed/NCBI View Article : Google Scholar

3 

Cappabianca P, Alfieri A, Colao A, Ferone D, Lombardi G and de Divitiis E: Endoscopic endonasal transsphenoidal approach: An additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg. 9:109–117. 1999.PubMed/NCBI View Article : Google Scholar

4 

Li A, Liu W, Cao P, Zheng Y, Bu Z and Zhou T: Endoscopic Versus microscopic transsphenoidal surgery in the treatment of pituitary adenoma: A systematic review and meta-analysis. World Neurosurg. 101:236–246. 2017.PubMed/NCBI View Article : Google Scholar

5 

Messerer M, De battista JC, Raverot G, Kassis S, Dubourg J, Lapras V, Trouillas J, Perrin G and Jouanneau E: Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus. 30(E11)2011.PubMed/NCBI View Article : Google Scholar

6 

Razak AA, Horridge M, Connolly DJ, Warren DJ, Mirza S, Muraleedharan V and Sinha S: Comparison of endoscopic and microscopic trans-sphenoidal pituitary surgery: early results in a single centre. Br J Neurosurg. 27:40–43. 2013.PubMed/NCBI View Article : Google Scholar

7 

Guo S, Wang Z, Kang X, Xin W and Li X: A Meta-Analysis of endoscopic vs. microscopic transsphenoidal surgery for non-functioning and functioning pituitary adenomas: Comparisons of efficacy and safety. Front Neurol. 12(614382)2021.PubMed/NCBI View Article : Google Scholar

8 

Gao Y, Zhong C, Wang Y, Xu S, Guo Y, Dai C, Zheng Y, Wang Y, Luo Q and Jiang J: Endoscopic versus microscopic transsphenoidal pituitary adenoma surgery: A meta-analysis. World J Surg Onc. 12(94)2014.PubMed/NCBI View Article : Google Scholar

9 

Neal JG, Patel SJ, Kulbersh JS, Osguthorpe JD and Schlosser RJ: Comparison of techniques for transsphenoidal pituitary surgery. Am J Rhinol. 21:203–206. 2007.PubMed/NCBI View Article : Google Scholar

10 

Graham SM, Iseli TA, Karnell LH, Clinger JD, Hitchon PW and Greenlee JD: Endoscopic approach for pituitary surgery improves rhinologic outcomes. Ann Otol Rhinol Laryngol. 118:630–635. 2009.PubMed/NCBI View Article : Google Scholar

11 

Chatzidakis S, Anagiotos A, Fotakopoulos G, Georgakopoulou VE, Tarantinos K, Papalexis P, Aravantinou-Fatorou A, Sklapani P, Mathioudakis N, Trakas N, et al: Comparison of the endoscopic endonasal to microscopic sublabial transsphenoidal approach in a case series of pituitary macroadenomas. Med Int (Lond). 3(6)2023.PubMed/NCBI View Article : Google Scholar

12 

Ciric I, Ragin A, Baumgartner C and Pierce D: Complications of transsphenoidal surgery: Results of a National survey, review of the literature, and personal experience. Neurosurgery. 40:225–236; discussion 236-7. 1997.PubMed/NCBI View Article : Google Scholar

13 

O'Malley BW Jr, Grady MS, Gabel BC, Cohen MA, Heuer GG, Pisapia J, Bohman LE and Leibowitz JM: Comparison of endoscopic and microscopic removal of pituitary adenomas: Single-surgeon experience and the learning curve. Neurosurg Focus. 25(E10)2008.PubMed/NCBI View Article : Google Scholar

14 

Locatelli M, Bertani G, Carrabba G, Rampini P, Zavanone M, Caroli M, Sala E, Ferrante E, Gaini SM, Spada A, et al: The trans-sphenoidal resection of pituitary adenomas in elderly patients and surgical risk. Pituitary. 16:146–151. 2013.PubMed/NCBI View Article : Google Scholar

15 

Hong J, Ding X and Lu Y: Clinical analysis of 103 elderly patients with pituitary adenomas: Transsphenoidal surgery and follow-up. J Clin Neurosci. 15:1091–1095. 2008.PubMed/NCBI View Article : Google Scholar

16 

Azab MA, O'Hagan M, Abou-Al-Shaar H, Karsy M, Guan J and Couldwell WT: Safety and outcome of transsphenoidal pituitary adenoma resection in elderly patients. World Neurosurg. 122:e1252–e1258. 2019.PubMed/NCBI View Article : Google Scholar

17 

Zhan R, Ma Z, Wang D and Li X: Pure endoscopic endonasal transsphenoidal approach for nonfunctioning pituitary adenomas in the elderly: Surgical outcomes and complications in 158 patients. World Neurosurg. 84:1572–1578. 2015.PubMed/NCBI View Article : Google Scholar

18 

Marenco HA, Zymberg ST, Santos Rde P and Ramalho CO: Surgical treatment of non-functioning pituitary macroadenomas by the endoscopic endonasal approach in the elderly. Arq Neuropsiquiatr. 73:764–769. 2015.PubMed/NCBI View Article : Google Scholar

19 

Chinezu R, Fomekong F, Lasolle H, Trouillas J, Vasiljevic A, Raverot G and Jouanneau E: Risks and benefits of endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas in patients of the ninth decade. World Neurosurg. 106:315–321. 2017.PubMed/NCBI View Article : Google Scholar

20 

Fujimoto K, Yano S, Shinojima N, Hide T and Kuratsu JI: Endoscopic endonasal transsphenoidal surgery for patients aged over 80 years with pituitary adenomas: Surgical and follow-up results. Surg Neurol Int. 8(213)2017.PubMed/NCBI View Article : Google Scholar

21 

Gondim JA, Almeida JP, de Albuquerque LA, Gomes E, Schops M and Mota JI: Endoscopic endonasal transsphenoidal surgery in elderly patients with pituitary adenomas. J Neurosurg. 123:31–38. 2015.PubMed/NCBI View Article : Google Scholar

22 

Wilson PJ, Omay SB, Kacker A, Anand VK and Schwartz TH: Endonasal endoscopic pituitary surgery in the elderly. J Neurosurg. 128:429–436. 2018.PubMed/NCBI View Article : Google Scholar

Related Articles

Journal Cover

November-2023
Volume 19 Issue 5

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Faropoulos K, Gioti I, Georgakopoulou VE, Spandidos DA, Papalexis P, Lempesis IG, Trakas N, Trakas I, Anagiotos A, Fotakopoulos G, Fotakopoulos G, et al: When age is not an obstacle: A case series of endoscopic transsphenoidal resection of pituitary macroadenomas in older patients. Biomed Rep 19: 86, 2023
APA
Faropoulos, K., Gioti, I., Georgakopoulou, V.E., Spandidos, D.A., Papalexis, P., Lempesis, I.G. ... Fotakopoulos, G. (2023). When age is not an obstacle: A case series of endoscopic transsphenoidal resection of pituitary macroadenomas in older patients. Biomedical Reports, 19, 86. https://doi.org/10.3892/br.2023.1668
MLA
Faropoulos, K., Gioti, I., Georgakopoulou, V. E., Spandidos, D. A., Papalexis, P., Lempesis, I. G., Trakas, N., Trakas, I., Anagiotos, A., Fotakopoulos, G."When age is not an obstacle: A case series of endoscopic transsphenoidal resection of pituitary macroadenomas in older patients". Biomedical Reports 19.5 (2023): 86.
Chicago
Faropoulos, K., Gioti, I., Georgakopoulou, V. E., Spandidos, D. A., Papalexis, P., Lempesis, I. G., Trakas, N., Trakas, I., Anagiotos, A., Fotakopoulos, G."When age is not an obstacle: A case series of endoscopic transsphenoidal resection of pituitary macroadenomas in older patients". Biomedical Reports 19, no. 5 (2023): 86. https://doi.org/10.3892/br.2023.1668